chrX-30308866-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_000475.5(NR0B1):c.498G>A(p.Arg166=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.248 in 1,204,414 control chromosomes in the GnomAD database, including 30,177 homozygotes. There are 100,218 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.30 ( 4242 hom., 9254 hem., cov: 23)
Exomes 𝑓: 0.24 ( 25935 hom. 90964 hem. )
Consequence
NR0B1
NM_000475.5 synonymous
NM_000475.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.477
Genes affected
NR0B1 (HGNC:7960): (nuclear receptor subfamily 0 group B member 1) This gene encodes a protein that contains a DNA-binding domain. The encoded protein acts as a dominant-negative regulator of transcription which is mediated by the retinoic acid receptor. This protein also functions as an anti-testis gene by acting antagonistically to Sry. Mutations in this gene result in both X-linked congenital adrenal hypoplasia and hypogonadotropic hypogonadism. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant X-30308866-C-T is Benign according to our data. Variant chrX-30308866-C-T is described in ClinVar as [Benign]. Clinvar id is 256225.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-30308866-C-T is described in Lovd as [Pathogenic]. Variant chrX-30308866-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.477 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.681 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NR0B1 | NM_000475.5 | c.498G>A | p.Arg166= | synonymous_variant | 1/2 | ENST00000378970.5 | NP_000466.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NR0B1 | ENST00000378970.5 | c.498G>A | p.Arg166= | synonymous_variant | 1/2 | 1 | NM_000475.5 | ENSP00000368253 | P1 |
Frequencies
GnomAD3 genomes AF: 0.296 AC: 32511AN: 109841Hom.: 4241 Cov.: 23 AF XY: 0.285 AC XY: 9220AN XY: 32299
GnomAD3 genomes
AF:
AC:
32511
AN:
109841
Hom.:
Cov.:
23
AF XY:
AC XY:
9220
AN XY:
32299
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.334 AC: 56300AN: 168478Hom.: 7800 AF XY: 0.330 AC XY: 19196AN XY: 58244
GnomAD3 exomes
AF:
AC:
56300
AN:
168478
Hom.:
AF XY:
AC XY:
19196
AN XY:
58244
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.244 AC: 266596AN: 1094516Hom.: 25935 Cov.: 36 AF XY: 0.252 AC XY: 90964AN XY: 360844
GnomAD4 exome
AF:
AC:
266596
AN:
1094516
Hom.:
Cov.:
36
AF XY:
AC XY:
90964
AN XY:
360844
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.296 AC: 32552AN: 109898Hom.: 4242 Cov.: 23 AF XY: 0.286 AC XY: 9254AN XY: 32366
GnomAD4 genome
AF:
AC:
32552
AN:
109898
Hom.:
Cov.:
23
AF XY:
AC XY:
9254
AN XY:
32366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 01, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Congenital adrenal hypoplasia, X-linked Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Congenital adrenal hypoplasia, X-linked;C1848296:46,XY sex reversal 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at